Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model

Neurotoxicity Research

Volumn 19, Issue 1, 2011, Pages 195-209

  García Del Barco, Diana ^a   Pérez Saad, Héctor ^b   Rodríguez, Valia ^c   Marín, Javier ^c   Falcón, Viviana ^a   Martín, Jorge ^a   Cibrian, Danay ^a   Berlanga, Jorge ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^c CUBAN NEUROSCIENCE CENTER   (Cuba)

Author keywords

1,2 diacetylbenzene; Amyotrophic lateral sclerosis; Behavioral test; Compound muscle action potential; Epidermal growth factor; Growth hormone releasing peptide 6

Indexed keywords

1,2 DIACETYLBENZENE; ACETOPHENONE DERIVATIVE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; PLACEBO; RECOMBINANT EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; EXTENSOR MUSCLE; FEMALE; GAIT; LATENT PERIOD; LEG MUSCLE; MOUSE; MUSCLE ACTION POTENTIAL; MUSCLE REFLEX; MUSCLE STRENGTH; NEUROPATHY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EPIDERMAL GROWTH FACTOR; FEMALE; GROWTH HORMONE-RELEASING HORMONE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES;

ANIMALIA; MUS;

EID: 78650546893     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-010-9160-8     Document Type: Article

References (105)

1. ME Acevedo N Leon H Perez-Saad JD Garcia 2000 Protective effect of a mixture of gangliosides in acrylamide neuropathy in mice Rev Neurol 30 11 1097 1098 1:STN:280:DC%2BD3cvgt1Wqsw%3D%3D 10904958
2. A Al-Chalabi CC Miller 2003 Neurofilaments and neurological disease Bioessays 25 4 346 355 1:CAS:528:DC%2BD3sXjtVylsLk%3D 12655642 10.1002/bies.10251
3. J Archer 2008 Tests for emotionality in rats and mice: a review Anim Behav 21 205 235 10.1016/S0003-3472(73)80065-X
4. JD Atkin MA Farg BJ Turner D Tomas JA Lysaght, et al. 2006 Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1 J Biol Chem 281 40 30152 30165 1:CAS:528:DC%2BD28XhtVahsbvI 16847061 10.1074/jbc.M603393200
5. JD Atkin MA Farg AK Walker C McLean D Tomas MK Horne 2008 Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis Neurobiol Dis 30 3 400 407 1:CAS:528:DC%2BD1cXmtlShsrY%3D 18440237 10.1016/j.nbd.2008.02.009
6. T Atkinson J Whitfield B Chakravarthy 2009 The phosphatase inhibitor, okadaic acid, strongly protects primary rat cortical neurons from lethal oxygen-glucose deprivation Biochem Biophys Res Commun 378 3 394 398 1:CAS:528:DC%2BD1cXhsFClsrzJ 19026614 10.1016/j.bbrc.2008.11.036
7. SC Barber PJ Shaw 2009 Oxidative stress in ALS: key role in motor neuron injury and therapeutic target Free Radic Biol Med 48 5 629 641 19969067 10.1016/j.freeradbiomed.2009.11.018 1:CAS:528:DC%2BC3cXhtlGhtb0%3D
8. E Beghi T Mennini C Bendotti P Bigini G Logroscino A Chio, et al. 2007 The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure Curr Med Chem 14 30 3185 3200 1:CAS:528:DC%2BD1cXhtlSrsb0%3D 18220753 10.2174/092986707782793862
9. J Berlanga ME Caballero D Ramirez A Torres C Valenzuela J Lodos, et al. 1998 Epidermal growth factor protects against carbon tetrachloride-induced hepatic injury Clin Sci (Lond) 94 3 219 223 1:CAS:528:DyaK1cXisVKnu78%3D
10. J Berlanga P Prats D Remirez R Gonzalez P Lopez-Saura J Aguiar, et al. 2002 Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage Am J Pathol 161 2 373 379 1:CAS:528:DC%2BD38XntFektb8%3D 12163361
11. J Berlanga J Lodos P Lopez-Saura 2002 Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents Burns 28 5 435 442 12163282 10.1016/S0305-4179(02)00023-2
12. J Berlanga D Cibrian L Guevara H Dominguez JS Alba A Seralena, et al. 2007 Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction Clin Sci (Lond) 112 4 241 250 1:CAS:528:DC%2BD2sXjt1Shu7o%3D 10.1042/CS20060103
13. LI Bruijn DW Cleveland 1996 Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease Neuropathol Appl Neurobiol 22 5 373 387 1:STN:280:DyaK2s%2FosVKisQ%3D%3D 8930947 10.1111/j.1365-2990.1996.tb00907.x
14. ME Caballero J Berlanga D Ramirez P Lopez-Saura R Gozalez DN Floyd, et al. 2001 Epidermal growth factor reduces multiorgan failure induced by thioacetamide Gut 48 1 34 40 1:CAS:528:DC%2BD3MXntFKguw%3D%3D 11115820 10.1136/gut.48.1.34
15. E Canali A Chiari P Sola V Fioravanti F Valzania R Pentore, et al. 2009 Rapidly progressive amyotrophic lateral sclerosis in a young patient with hereditary neuropathy with liability to pressure palsies Amyotroph Lateral Scler 12 1 2 10.1080/17482960902964440
16. D Casper M Blum 1995 Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture J Neurochem 65 3 1016 1026 1:CAS:528:DyaK2MXns1ejur4%3D 7643081 10.1046/j.1471-4159.1995.65031016.x
17. N Chand J Pillar W Diamantis RD Sofia 1988 Inhibition of allergic histamine release from rat peritoneal mast cells by azelastine. Interaction with selected antiasthmatic drugs Int Arch Allergy Appl Immunol 86 3 256 260 1:CAS:528:DyaL1cXltVCmsbg%3D 2456990 10.1159/000234582
18. Y Charnay C Paulin F Dray P-M Dubois 2004 Distribution of enkephalin in human fetus and infant spinal cord: an immunofluorescence study J Comp Neurol 223 3 415 423 10.1002/cne.902230307
19. H Chen B Liu AH Neufeld 2007 Epidermal growth factor receptor in adult retinal neurons of rat, mouse, and human J Comp Neurol 500 2 299 310 1:CAS:528:DC%2BD2sXmsVWmtw%3D%3D 17111374 10.1002/cne.21161
20. D Cibrian H Ajamieh J Berlanga OS Leon JS Alba MJ Kim, et al. 2006 Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure Clin Sci (Lond) 110 5 563 573 1:CAS:528:DC%2BD28XjtlCgs7c%3D 10.1042/CS20050374
21. DW Cleveland JD Rothstein 2001 From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS Nat Rev Neurosci 2 11 806 819 1:CAS:528:DC%2BD38Xmt1WitLs%3D 11715057 10.1038/35097565
22. JP Crow NY Calingasan J Chen JL Hill MF Beal 2005 Manganese porphyrin given at symptom onset markedly extends survival of ALS mice Ann Neurol 58 2 258 265 1:CAS:528:DC%2BD2MXps1Cgu78%3D 16049935 10.1002/ana.20552
23. L de Alonso M Gutierrez JM Roda F Carceller E Diez-Tejedor 2006 Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke J Neurol Sci 247 2 121 129 10.1016/j.jns.2006.03.022 1:CAS:528: DC%2BD28XpsVKlurk%3D
24. CA de Delgado-Rubin JA Chowen J Argente LM Frago 2006 Growth hormone releasing peptide-6 acts as a survival factor in glutamate-induced excitotoxicity J Neurochem 99 3 839 849 10.1111/j.1471-4159.2006.04122.x 1:CAS:528:DC%2BD28Xht1eju73N
25. JP De la Cruz CF de la Sanchez 1991 Does the association dipyridamole-aspirin only act by a functional synergism? Gen Pharmacol 22 2 271 274 2055420
26. KJ De Vos AJ Grierson S Ackerley CC Miller 2008 Role of axonal transport in neurodegenerative diseases Annu Rev Neurosci 31 151 173 18558852 10.1146/annurev.neuro.31.061307.090711 1:CAS:528:DC%2BD1cXpt12nsro%3D
27. MB Delisle S Carpenter 1984 Neurofibrillary axonal swellings and amyotrophic lateral sclerosis J Neurol Sci 63 2 241 250 1:STN:280: DyaL2c7mtl2qsA%3D%3D 6538591 10.1016/0022-510X(84)90199-0
28. H Dreyfus J Sahel V Heidinger S Mohand-Said B Guerold E Meuillet, et al. 1998 Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents Ann N Y Acad Sci 845 240 252 1:CAS:528:DyaK1cXks12hu7w%3D 9668358 10.1111/j.1749-6632.1998.tb09677.x
29. T Dunckley MJ Huentelman DW Craig JV Pearson S Szelinger K Joshipura, et al. 2007 Whole-genome analysis of sporadic amyotrophic lateral sclerosis N Engl J Med 357 8 775 788 1:CAS:528:DC%2BD2sXpsF2gtL0%3D 17671248 10.1056/NEJMoa070174
30. A Echaniz-Laguna B Degos M Mohr R Kessler E Urban-Kraemer C Tranchant 2006 A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP Muscle Nerve 33 3 356 362 16320313 10.1002/mus.20475
31. SB Edelson 2000 Environmental toxicity in the possible etiology of sporadic amyotrophic lateral sclerosis J Nutr Environ Med 10 4 311 320 1:CAS:528:DC%2BD3MXot1Kntg%3D%3D 10.1080/13590840020013301
32. DM Finkel EM Capmourteres 1999 Combination of nondepolarizing muscle relaxants: synergism of potentiation Rev Argent Anestesiol 57 3 145 154
33. LM Frago C Paneda SL Dickson AK Hewson J Argente JA Chowen 2002 Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection Endocrinology 143 10 4113 4122 1:CAS:528:DC%2BD38Xnt1ygt7c%3D 12239123 10.1210/en.2002-220261
34. LM Frago C Paneda J Argente JA Chowen 2005 Growth hormone-releasing peptide-6 increases insulin-like growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurones J Neuroendocrinol 17 11 701 710 1:CAS:528:DC%2BD2MXhtF2it73P 16218998 10.1111/j.1365-2826.2005.01347.x
35. N Gago V Vellana-Adalid AB Evercooren M Schumacher 2003 Control of cell survival and proliferation of postnatal PSA-NCAM(+) progenitors Mol Cell Neurosci 22 2 162 178 1:CAS:528:DC%2BD3sXisFWmtbo%3D 12676527 10.1016/S1044-7431(02)00030-1
36. RM Garruto R Yanagihara DC Gajdusek 1990 Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific Environ Geochem Health 12 1-2 137 151 10.1007/BF01734063
37. A Goto YL Wang T Kabuta R Setsuie H Osaka A Sawa, et al. 2009 Proteomic and histochemical analysis of proteins involved in the dying-back-type of axonal degeneration in the gracile axonal dystrophy (gad) mouse Neurochem Int 54 5-6 330 338 1:CAS:528:DC%2BD1MXivVGltL0%3D 19154771 10.1016/j.neuint.2008.12.012
38. S Haginomori S Wada A Takamaki R Nonaka H Takenaka T Takubo 2008 A new method for measuring compound muscle action potentials in facial palsy: a preliminary study Muscle Nerve 37 6 764 769 18506721 10.1002/mus.21034
39. MR Hara N Agrawal SF Kim MB Cascio M Fujimuro Y Ozeki, et al. 2005 S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding Nat Cell Biol 7 7 665 674 1:CAS:528:DC%2BD2MXlslWht7c%3D 15951807 10.1038/ncb1268
40. C Harms J Bosel M Lautenschlager U Harms JS Braun H Hortnagl, et al. 2004 Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization Mol Cell Neurosci 25 1 69 82 1:CAS:528:DC%2BD2cXhtVOlt7Y%3D 14962741 10.1016/j.mcn.2003.09.012
41. S Heck F Lezoualc'h S Engert C Behl 1999 Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB J Biol Chem 274 14 9828 9835 1:CAS:528:DyaK1MXisVWks7w%3D 10092673 10.1074/jbc.274.14.9828
42. RD Henderson JR Daube 2004 Decrement in surface-recorded motor unit potentials in amyotrophic lateral sclerosis Neurology 63 9 1670 1674 15534253
43. R Henderson F Baumann N Hutchinson P McCombe 2009 CMAP decrement in ALS Muscle Nerve 39 4 555 556 19296459 10.1002/mus.21105
44. D Hicks V Heidinger S Mohand-Said J Sahel H Dreyfus 1998 Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia Gen Pharmacol 30 3 265 273 1:CAS:528:DyaK1cXlsFaksw%3D%3D 9510073
45. A Hirano H Donnenfeld S Sasaki I Nakano 1984 Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis J Neuropathol Exp Neurol 43 5 461 470 1:STN:280:DyaL2c3ptFCqsA%3D%3D 6540799 10.1097/00005072- 198409000-00001
46. EL Holzbaur 2004 Motor neurons rely on motor proteins Trends Cell Biol 14 5 233 240 1:CAS:528:DC%2BD2cXjvVemurY%3D 15130579 10.1016/j.tcb.2004.03.009
47. S Hosback O Hardiman CM Nolan MA Doyle G Gorman C Lynch, et al. 2007 Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis Growth Horm IGF Res 17 6 472 479 1:CAS:528:DC%2BD2sXht1ylsrbI 17697791 10.1016/j.ghir.2007.06.002
48. BD Jankovic J Radulovic 1992 Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity Int J Neurosci 67 1-4 241 270 1:STN:280:DyaK3s3ptlCgug%3D%3D 1305637 10.3109/00207459208994788
49. DM Jaworski P Soloway J Caterina WA Falls 2006 Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits J Neurobiol 66 1 82 94 1:CAS:528:DC%2BD28XltVaqsw%3D%3D 16216006 10.1002/neu.20205
50. JP Julien J Kriz 2006 Transgenic mouse models of amyotrophic lateral sclerosis Biochim Biophys Acta 1762 11-12 1013 1024 1:CAS:528:DC%2BD28Xht1CgsLnO 16675207
51. BK Kaspar J Llado N Sherkat JD Rothstein FH Gage 2003 Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model Science 301 5634 839 842 1:CAS:528:DC%2BD3sXmtVGqs7c%3D 12907804 10.1126/science.1086137
52. MS Kim MI Sabri VH Miller RJ Kayton DA Dixon PS Spencer 2001 1,2-diacetylbenzene, the neurotoxic metabolite of a chromogenic aromatic solvent, induces proximal axonopathy Toxicol Appl Pharmacol 177 2 121 131 1:CAS:528:DC%2BD3MXovFGhu74%3D 11740911 10.1006/taap.2001.9301
53. MS Kim SB Hashemi PS Spencer MI Sabri 2002 Amino acid and protein targets of 1,2-diacetylbenzene, a potent aromatic gamma-diketone that induces proximal neurofilamentous axonopathy Toxicol Appl Pharmacol 183 1 55 65 1:CAS:528:DC%2BD38Xms1Wmtrc%3D 12217642 10.1006/taap.2002.9456
54. MK Kim KS Kim JH Chung JH Kim JR Kim HY Chung, et al. 2007 Environmental metabolite, 1,2-diacetylbenzene, produces cytotoxicity through ROS generation in HUVEC cells J Toxicol Environ Health A 70 15-16 1336 1343 1:CAS:528: DC%2BD2sXotV2ktrk%3D 17654252 10.1080/15287390701428895
55. MS Kim MK Kim KS Kim JH Chung SJ Kim JH Kim, et al. 2008 Cytotoxicity of 1,2-diacetylbenzene in human neuroblastoma SHSY5Y cells is mediated by oxidative stress Toxicology 243 1-2 216 223 1:CAS:528:DC%2BD2sXhsVCgtrjE 18063464 10.1016/j.tox.2007.10.012
56. J Kriz G Gowing JP Julien 2003 Efficient three-drug cocktail for disease induced by mutant superoxide dismutase Ann Neurol 53 4 429 436 1:CAS:528:DC%2BD3sXjtFGitbg%3D 12666110 10.1002/ana.10500
57. EC Lai KJ Felice BW Festoff MJ Gawel DF Gelinas R Kratz, et al. 1997 Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group Neurology 49 6 1621 1630 1:CAS:528:DyaK1cXitVCnsg%3D%3D 9409357
58. AC Lepore C Haenggeli M Gasmi KM Bishop RT Bartus NJ Maragakis, et al. 2007 Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS Brain Res 1185 256 265 1:CAS:528:DC%2BD2sXhtlykurrM 17963733 10.1016/j.brainres.2007.09.034
59. F Letournel A Bocquet F Dubas A Barthelaix J Eyer 2003 Stable tubule only polypeptides (STOP) proteins co-aggregate with spheroid neurofilaments in amyotrophic lateral sclerosis J Neuropathol Exp Neurol 62 12 1211 1219 1:CAS:528:DC%2BD2cXht1Ogug%3D%3D 14692697
60. S Lin LW Fan PG Rhodes Z Cai 2009 Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats Exp Neurol 217 2 361 370 1:CAS:528:DC%2BD1MXlvF2kt74%3D 19332057 10.1016/j.expneurol.2009.03.021
61. SA Lipton 2007 Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation Curr Drug Targets 8 5 621 632 1:CAS:528:DC%2BD2sXlsVWmurc%3D 17504105 10.2174/ 138945007780618472
62. XX Liu J Zhang JY Zheng S Zhang YS Xu DX Kang, et al. 2009 Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis Muscle Nerve 39 3 304 309 19208412 10.1002/mus.21144
63. RM LoPachin BS Jortner ML Reid S Das 2003 Gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots Toxicol Appl Pharmacol 193 1 29 46 1:CAS:528:DC%2BD3sXovVWms78%3D 14613714 10.1016/j.taap.2003.07.005
64. JM Matthieu V Comte M Tosic P Honegger 1992 Myelin gene expression during demyelination and remyelination in aggregating brain cell cultures J Neuroimmunol 40 2-3 231 234 1:CAS:528:DyaK3sXlslCnug%3D%3D 1385472 10.1016/0165-5728(92)90138-B
65. V Mitchell M Mazzuca JC Beauvillain 1995 The fetal expression of proenkephalin mRNAs and Met-enkephalin immunoreactivity in the hypothalamoseptal tract and adjacent hypothalamic areas of the guinea pig brain Brain Res Dev Brain Res 86 1-2 67 80 1:CAS:528:DyaK2MXlvVSqurY%3D 7656433 10.1016/0165- 3806(95)00010-B
66. M Mitne-Neto CR Ramos DC Pimenta JS Luz AL Nishimura FA Gonzales, et al. 2007 A mutation in human VAP-B-MSP domain, present in ALS patients, affects the interaction with other cellular proteins Protein Expr Purif 55 1 139 146 1:CAS:528:DC%2BD2sXpt1antL8%3D 17540579 10.1016/j.pep.2007.04.007
67. J Motil M Dubey WK Chan TB Shea 2007 Inhibition of dynein but not kinesin induces aberrant focal accumulation of neurofilaments within axonal neurites Brain Res 1164 125 131 1:CAS:528:DC%2BD2sXovFGntLk%3D 17640622 10.1016/j.brainres.2006.09.108
68. H Nakajima W Amano A Fujita A Fukuhara YT Azuma F Hata, et al. 2007 The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death J Biol Chem 282 36 26562 26574 1:CAS:528:DC%2BD2sXpslGjtb0%3D 17613523 10.1074/jbc.M704199200
69. T Niidome N Morimoto S Iijima A Akaike T Kihara H Sugimoto 2006 Mechanisms of cell death of neural progenitor cells caused by trophic support deprivation Eur J Pharmacol 548 13 1 8 1:CAS:528:DC%2BD28XpvFektrs%3D 16965769 10.1016/j.ejphar.2006.07.052
70. K Okamoto S Hirai M Shoji Y Senoh T Yamazaki 1990 Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis Acta Neuropathol 80 2 222 226 1:STN:280:DyaK3czlvVSnug%3D%3D 2202191 10.1007/BF00308929
71. C Paneda AI Arroba LM Frago AM Holm J Romer J Argente, et al. 2003 Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats Neuroreport 14 12 1633 1635 1:CAS:528:DC%2BD3sXntlyrtrs%3D 14502090 10.1097/00001756-200308260-00018
72. H Peng TC Wen J Tanaka N Maeda S Matsuda J Desaki, et al. 1998 Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries J Cereb Blood Flow Metab 18 4 349 360 1:CAS:528:DyaK1cXislSlsrs%3D 9538899 10.1097/00004647-199804000- 00002
73. A Pierce H Mirzaei F Muller WE De AB Taylor S Leonard, et al. 2008 GAPDH is conformationally and functionally altered in association with oxidative stress in mouse models of amyotrophic lateral sclerosis J Mol Biol 382 5 1195 1210 1:CAS:528:DC%2BD1cXhtFWlt7nI 18706911 10.1016/j.jmb.2008.07.088
74. YA Rajabally S Jacob 2008 Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis Muscle Nerve 38 1 855 860 18508343 10.1002/mus.21010
75. KR Reuhl LA Lagunowich DL Brown 1994 Cytoskeleton and cell adhesion molecules: critical targets of toxic agents Neurotoxicology 15 1 133 145 1:CAS:528:DyaK2cXltVWhtbs%3D 8090353
76. M Rico MT Lorenzo JA Pazo FV Vega LF De la Cruz 1999 GHRP-6 in heifer and cow adenohypophisial cells separated by elutriation J Physiol Biochem 55 1 33 39 1:CAS:528:DyaK1MXltlOmsbo%3D 10494658
77. JD Rothstein 2009 Current hypotheses for the underlying biology of amyotrophic lateral sclerosis Ann Neurol 65 Suppl 1 S3 S9 1:CAS:528: DC%2BD1MXjtFKru7w%3D 19191304 10.1002/ana.21543
78. LP Rowland NA Shneider 2001 Amyotrophic lateral sclerosis N Engl J Med 344 22 1688 1700 1:CAS:528:DC%2BD3MXkslWjtbo%3D 11386269 10.1056/ NEJM200105313442207
79. MI Sabri SB Hashemi MR Lasarev PS Spencer 2007 Axonopathy-inducing 1,2-diacetylbenzene forms adducts with motor and cytoskeletal proteins required for axonal transport Neurochem Res 32 12 2152 2159 1:CAS:528:DC%2BD2sXht1Gks73N 17577667 10.1007/s11064-007-9392-z
80. T Satoh Y Enokido T Kubo M Yamada H Hatanaka 1998 Oxygen toxicity induces apoptosis in neuronal cells Cell Mol Neurobiol 18 6 649 666 1:CAS:528:DyaK1MXjtl2htQ%3D%3D 9876872 10.1023/A:1020269802315
81. GM Seigel L Chiu A Paxhia 2000 Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs Mol Vis 6 157 163 1:CAS:528:DC%2BD3cXntlKlsL8%3D 10973501
82. AV Serdiuk GN Levitskii NF Miasoedov VI Skvortsova 2007 The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax Zh Nevrol Psikhiatr Im S S Korsakova 107 4 29 39 1:STN:280:DC%2BD1cvpvVGruw%3D%3D 18379501
83. CA Shaw GU Hoglinger 2008 Neurodegenerative diseases: neurotoxins as sufficient etiologic agents? Neuromol Med 10 1 1 9 1:CAS:528: DC%2BD1cXjt1eitLw%3D 10.1007/s12017-007-8016-8
84. N Siddique T Siddique 2008 Genetics of amyotrophic lateral sclerosis Phys Med Rehabil Clin N Am 19 3 429 439 18625408 vii
85. CL Simpson A Al-Chalabi 2006 Amyotrophic lateral sclerosis as a complex genetic disease Biochim Biophys Acta 1762 11-12 973 985 1:CAS:528: DC%2BD28Xht1CgsLbL 16973338
86. MA Sirover 1999 New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase Biochim Biophys Acta 1432 2 159 184 1:CAS:528:DyaK1MXlt1eksLg%3D 10407139
87. MJ Strong 2003 The basic aspects of therapeutics in amyotrophic lateral sclerosis Pharmacol Ther 98 3 379 414 1:CAS:528:DC%2BD3sXktVOqsbs%3D 12782245 10.1016/S0163-7258(03)00040-8
88. K Sunaga H Takahashi DM Chuang R Ishitani 1995 Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain Neurosci Lett 200 2 133 136 1:CAS:528:DyaK2MXpsV2rtrw%3D 8614562 10.1016/0304-3940(95)12098-O
89. I Tesseur DJ Van K Bruynseels F Bronfman R Sciot LA Van, et al. 2000 Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord Am J Pathol 157 5 1495 1510 1:CAS:528:DC%2BD3cXosFyhsrw%3D 11073810
90. KD Thrall RA Gies AM Cartmell H Wu JJ Soelberg JA Klein 2007 A liquid chromatographic-mass spectrometric method to evaluate the distribution kinetics of 1,2-diethylbenzene and its metabolite 1,2-diacetylbenzene in the F344 male rat J Toxicol Environ Health A 70 1 67 72 1:CAS:528:DC%2BD2sXms1Omug%3D%3D 17162499 10.1080/15287390600751173
91. I Torres-Aleman V Barrios J Berciano 1998 The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis Neurology 50 3 772 776 1:STN:280:DyaK1c7otVGluw%3D%3D 9521273
92. M Tortarolo G Grignaschi N Calvaresi E Zennaro G Spaltro M Colovic, et al. 2006 Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease J Neurosci Res 83 1 134 146 1:CAS:528:DC%2BD28Xlt1SitA%3D%3D 16323214 10.1002/jnr.20715
93. DD Tshala-Katumbay VS Palmer RJ Kayton MI Sabri PS Spencer 2005 A new murine model of giant proximal axonopathy Acta Neuropathol 109 4 405 410 1:CAS:528:DC%2BD2MXjvF2ntLw%3D 15759132 10.1007/s00401-005-0982-z
94. DD Tshala-Katumbay VS Palmer MR Lasarev RJ Kayton MI Sabri PS Spencer 2006 Monocyclic and dicyclic hydrocarbons: structural requirements for proximal giant axonopathy Acta Neuropathol 112 3 317 324 1:CAS:528:DC%2BD28XosFWrsrw%3D 16874529 10.1007/s00401-006-0106-4
95. D Tshala-Katumbay V Monterroso R Kayton M Lasarev M Sabri P Spencer 2008 Probing mechanisms of axonopathy. Part I: protein targets of 1,2-diacetylbenzene, the neurotoxic metabolite of aromatic solvent 1,2-diethylbenzene Toxicol Sci 105 1 134 141 1:CAS:528:DC%2BD1cXps12iur4%3D 18502740 10.1093/toxsci/kfn103
96. D Tshala-Katumbay P Desjardins M Sabri R Butterworth P Spencer 2009 New insights into mechanisms of gamma-diketone-induced axonopathy Neurochem Res 34 11 1919 1923 1:CAS:528:DC%2BD1MXltFymt7o%3D 19404740 10.1007/s11064-009-9977-9
97. D Tshala-Katumbay V Monterroso R Kayton M Lasarev M Sabri P Spencer 2009 Probing mechanisms of axonopathy. Part II: protein targets of 2, 5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane Toxicol Sci 107 2 482 489 1:CAS:528:DC%2BD1MXhtVehtr8%3D 19033394 10.1093/toxsci/kfn241
98. Q Wang JL Johnson NY Agar JN Agar 2008 Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival PLoS Biol 6 7 e170 18666828 10.1371/journal.pbio.0060170 1:CAS:528:DC%2BD1cXhtVSjtLzN
99. T Watanabe R Kaji N Oka W Bara J Kimura 1994 Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy J Neurol Sci 122 2 140 143 1:CAS:528:DyaK2cXkvF2msbc%3D 8021696 10.1016/0022-510X(94)90290-9
100. Williamson TL, Cleveland DW (2001) Mechanism of motoneurone death in ALS. In: Neurodegenerative disorders: loss of function through gain of function. Springer, New York, pp 23-40
101. XH Wu SH Yang DY Duan HH Cheng YT Bao Y Zhang 2007 Anti-apoptotic effect of insulin in the control of cell death and neurologic deficit after acute spinal cord injury in rats J Neurotrauma 24 9 1502 1512 17892411 10.1089/neu.2006.0228
102. CJ Xian XF Zhou 2004 EGF family of growth factors: essential roles and functional redundancy in the nerve system Front Biosci 9 85 92 1:CAS:528:DC%2BD2cXhtFCktbo%3D 14766347 10.2741/1210
103. M Yamada Y Enokido T Ikeuchi H Hatanaka 1995 Epidermal growth factor prevents oxygen-triggered apoptosis and induces sustained signalling in cultured rat cerebral cortical neurons Eur J Neurosci 7 10 2130 2138 1:STN:280:DyaK287hvF2msw%3D%3D 8542070 10.1111/j.1460-9568.1995.tb00635.x
104. S Zausinger T Westermaier N Plesnila HJ Steiger R Schmid-Elsaesser 2003 Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen Stroke 34 6 1526 1532 1:CAS:528:DC%2BD3sXktVKnu7c%3D 12730554 10.1161/01.STR.0000070841. 31224.29
105. Y Zhang L Wang Y Fu H Song H Zhao M Deng, et al. 2008 Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis Amyotroph Lateral Scler 4 1 2 10.1080/17482960802588059